SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-369403
Filing Date
2017-12-14
Accepted
2017-12-14 15:35:04
Documents
11
Period of Report
2018-01-25
Effectiveness Date
2017-12-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d493749ddef14a.htm DEF 14A 613163
2 GRAPHIC g493749dsp3.jpg GRAPHIC 6866
3 GRAPHIC g493749g1212073729267.jpg GRAPHIC 7343
4 GRAPHIC g493749g22s75.jpg GRAPHIC 1754
5 GRAPHIC g493749naa1.jpg GRAPHIC 1897
6 GRAPHIC g493749naa2.jpg GRAPHIC 2116
7 GRAPHIC g493749naa3.jpg GRAPHIC 1894
8 GRAPHIC g493749naa4.jpg GRAPHIC 1893
9 GRAPHIC g493749page34.jpg GRAPHIC 6804
10 GRAPHIC g493749page35.jpg GRAPHIC 2175
11 GRAPHIC g493749pc1.jpg GRAPHIC 1781
  Complete submission text file 0001193125-17-369403.txt   663298
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 171256080
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences